RIO DE JANEIRO, BRAZIL – In this movement, some sectors stood out in the face of the Covid-19 pandemic, such as pharma chemicals and pharmaceuticals.
For every R$100 (US$19) invested by Brazilian companies in Research and Development (R&D), R$69 comes from industry. It is what a report from the National Confederation of Industry (CNI), released on Monday, February 7, points out.
Between 2016 and 2019, in current values, the contribution in process and product innovation grew 33.4% – from R$12.7 billion to R$16.9 billion, a percentage above the 11.2% of accumulated inflation in the period (IPCA).
In this movement, some sectors stand out, such as pharma chemical and pharmaceutical products, which expanded its investments by 63.9%, in the decade, from R$955 million to R$1.6 billion. From 2018 to 2019 alone, the increase in the amount invested in the sector was 7.9%, or R$115 million. Motor vehicle companies, meanwhile, represent those that invested the most in R&D in the period: more than R$2.8 billion in 2019 alone. Next comes the chemical sector, with an investment of around R$2.5 billion in R&D.
The data are in the Industry Sector Profile. The portal gathers data on the labor market, taxation, production, foreign trade, costs, innovation, and investment from 33 sectors of Brazilian industry.
Through the tool, it is possible to create rankings and comparisons between the sectors and the available indicators and calculate the evolution of the numbers over the historical series in the cutout that the user prefers.
“The numbers leave no doubt about the relevance of the industrial sector for Brazil. It is responsible for 20% of the GDP and 20% of the formal jobs in the country, 69% of Brazilian exports of goods and services, 69% of business investments in R&D, and 33% of federal tax collection,” comments CNI’s president, Robson Braga de Andrade.